蛋白尿改变尿钠排泄与不良肾脏结局之间的关系:KNOW-CKD研究结果
该前瞻性观察性队列研究纳入967例CKD G1-G5期患者,基线测量24小时尿钠和尿蛋白排泄,中位随访4.1年,主要结局为CKD进展(eGFR下降≥50%或启动肾脏替代治疗)。蛋白尿与钠排泄对主要结局存在显著交互作用(P=0.006):蛋白尿<0.5 g/d者钠排泄与结局无关;蛋白尿≥0.5 g/d者尿钠每增加1.0 g/d,不良肾脏结局风险升高29%。
要点
- 蛋白尿与尿钠排泄对CKD进展存在显著交互作用(P=0.006)。
- 蛋白尿<0.5 g/d者,尿钠排泄与主要结局无关联。
- 蛋白尿≥0.5 g/d者,尿钠每增1.0 g/d,不良肾脏结局风险升高29%。
核心结论
- 尿钠排泄较高与不良肾脏结局风险增加的相关性在蛋白尿水平较高的患者中更强。
研究设计与样本
- 前瞻性观察性队列研究,纳入2011年至2016年间967例CKD G1至G5期患者,基线测量24小时尿钠和尿蛋白排泄。
主要发现
- 中位随访4.1年期间,287例参与者(29.7%)发生主要结局事件。
- 蛋白尿与钠排泄对主要结局存在显著交互作用(P=0.006)。
- 蛋白尿<0.5 g/d者,钠排泄与主要结局无关联。
- 蛋白尿≥0.5 g/d者,尿钠每增加1.0 g/d与不良肾脏结局风险升高29%相关。
- 蛋白尿≥0.5 g/d者中,尿钠<3.4 g/d和≥3.4 g/d的风险比(95%CI)分别为2.32(1.50-3.58)和5.71(3.58-9.11),参照组为蛋白尿<0.5 g/d且尿钠<3.4 g/d者。
关键数值与推荐
- 主要结局定义为eGFR下降≥50%或启动肾脏替代治疗。
- 蛋白尿≥0.5 g/d者中,尿钠<3.4 g/d的HR为2.32(95%CI 1.50-3.58),尿钠≥3.4 g/d的HR为5.71(95%CI 3.58-9.11),参照组为蛋白尿<0.5 g/d且尿钠<3.4 g/d者。
- 采用基线和第三年两次尿钠和尿蛋白排泄平均值进行的敏感性分析结果相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: High sodium intake is associated with increased proteinuria. Herein, we investigated whether proteinuria could modify the association between urinary sodium excretion and adverse kidney outcomes in patients with chronic kidney disease (CKD). METHODS: In this prospective observational cohort study, we included 967 participants with CKD stages G1 to G5 between 2011 and 2016, who measured 24-hour urinary sodium and protein excretion at baseline. The main predictors were urinary sodium and protein excretion levels. The primary outcome was CKD progression, which was defined as a ≥50% decline in the estimated glomerular filtration rate (eGFR) or the onset of kidney replacement therapy. RESULTS: During a median follow-up period of 4.1 years, the primary outcome events occurred in 287 participants (29.7%). There was a significant interaction between proteinuria and sodium excretion for the primary outcome (P = 0.006). In patients with proteinuria of <0.5 g/d, sodium excretion was not associated with the primary outcome. However, in patients with proteinuria of ≥0.5 g/d, a 1.0 g/d increase in sodium excretion was associated with a 29% higher risk of adverse kidney outcomes. Moreover, in patients with proteinuria of ≥0.5 g/d, the hazard ratios (HRs) (95% confidence intervals[CIs]) for sodium excretion of <3.4 and ≥3.4 g/d were 2.32 (1.50-3.58) and 5.71 (3.58-9.11), respectively, compared with HRs for patients with proteinuria of <0.5 g/d and sodium excretion of <3.4 g/d. In sensitivity analysis with 2 averaged values of sodium and protein excretion at baseline and third year, the results were similar. CONCLUSION: Higher urinary sodium excretion was more strongly associated with an increased risk of adverse kidney outcomes in patients with higher proteinuria levels.
引用
- Kim HJ, Jung CY, Kim HW, et al. Proteinuria Modifies the Relationship Between Urinary Sodium Excretion and Adverse Kidney Outcomes: Findings From KNOW-CKD. Kidney Int Rep. 2023. PMID: 37180512. doi:10.1016/j.ekir.2023.02.1078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。